About GenomOncology
GenomOncology is a Healthcare company based in Cleveland (United States) founded in 2012. Genomic data is transformed into actionable insights for precision medicine. GenomOncology has raised $6.09 million across 5 funding rounds from investors including TriStar Health Partners and JumpStart Ventures. GenomOncology offers products and services including Precision Oncology Platform, Data Enablement, Pathology Decision Support, Insights & Analytics, and Curation Services. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is GenomOncology LLC. Its competitors include Denali Therapeutics, MiRagen and Poseida Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
GenomOncology is a healthcare technology company enabling precision medicine by transforming genomic data into actionable information. It has developed a proprietary technology platform to streamline the use of next-generation sequencing in medicine and research. Precision Medicine Portfolio is a suite of products and services that addresses for precision medicine in molecular pathology and medical genetics, particularly in the field of oncology and other hereditary diseases. This portfolio supports test validation and production, clinical decision support, and analytics for both monitoring and discovery. Its other products include the GO Validation Toolkit, the GO Clinical Workbench, and GenomAnalytics. It also offers scientific services like test validation, customization, integration, and research.
- Headquarters Cleveland, United States
- SectorsHealthcare
- Website genomoncology.com
- Social LinkedIn X Facebook YouTube
- Legal Name Genomoncology Llc
- Total Equity Funding$6.09M (USD)
in 5 rounds
- Latest Funding Round$3.2M (USD), Series A
Apr 2020
- InvestorsTriStar Health Partners
& 1 more
Products & Services of GenomOncology
GenomOncology offers a comprehensive portfolio of products and services, including Precision Oncology Platform, Data Enablement, Pathology Decision Support, Insights & Analytics, and Curation Services.
Transforms complex data into actionable insights for cancer care.
Harnesses data to enhance operational efficiency in healthcare.
Processes genetic test results for clinical insights.
Analyzes patient data to improve cancer care outcomes.
Provides curated content for precision oncology solutions.
Apps and channels of GenomOncology
its YouTube channel GenomOncology has 127 subscribers and 15 videos.
Videos from GenomOncology
The most watched videos on GenomOncology's YouTube channel, GenomOncology (127 subscribers). Click a video to play it here.
More on GenomOncology.
Funding Insights of GenomOncology
GenomOncology has successfully raised a total of $6.09M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $3.2 million completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.09M
- Total Rounds 5
- Last Round Series A — $3.2M
- First Round $1.25M
(May 2012)
- Investors Count 2
All 5 funding rounds of GenomOncology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2020 | $3.2M | Series A | – | – | – |
| Nov 2019 | $1.39M | Seed | – | – | – |
| Feb 2014 | Seed | – | – | ||
| Jun 2012 | $250,000 | Seed | – | – | |
| May 2012 | $1.25M | Seed | – | – | – |
2 investors in total: 2 institutional.
Investors in GenomOncology
GenomOncology has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include TriStar Health Partners and JumpStart Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| tristarhealthpartners.com | ||||
Venture capital funding is provided to tech startups by JumpStart Ventures. | jumpstart.vc | Cleveland, United States |
Investor details for GenomOncology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of GenomOncology
27 people are tracked at GenomOncology (13 in leadership, 3 in board & advisors, 11 in team).
| Name | Role | Group |
|---|---|---|
Joe McCrone | Chief Operating Officer | Leadership |
Matt Stachowiak | VP, Product Innovation | Leadership |
Ian Maurer | CTO | Leadership |
Brad Wertz | Chairman & CEO Genomoncology | Leadership |
Tom Tibbits | VP Client Services And Operations | Leadership |
Scott Cesen | Senior Vice President Business Development | Leadership |
Justin Yeakley | Chief Information Security Officer | Leadership |
Jon Fretthold | VP, Client Services | Leadership |
Bryan Storch | Vice President, Client Services | Leadership |
Jeff Smith | Senior Vice President Finance | Leadership |
Hillary W. Bedell | Director, Content And Curation Services | Leadership |
Garreth Hippe | Chief Commercial Officer (cco) | Leadership |
Mike Flis | Director Of Application Development | Leadership |
Len Pagon | Board Member | Board & advisors |
Brian Laden | Board Member | Board & advisors |
Jeff Shiner | Board Member | Board & advisors |
Matt Spalding | Technical Architect | Team |
Anastasia Vassiliou | Senior Clinical Genomics Curator | Team |
Hillary Bedell | Content Team Manager | Team |
Chloe Allen | Software Engineer | Team |
7 more people are available in the full profile.
Complete people profiles for GenomOncology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of GenomOncology
3 dated milestones of GenomOncology across 8 years, from founding to its latest funding, stage changes and deals.
- Founded GenomOncology is founded.
- Funding First funding round of $1.2M.
- Funding Latest funding round, Series A, of $3.2M.
Competitors of GenomOncology
GenomOncology has 3 listed competitors in our database, 3 of them funded. They include Denali Therapeutics, MiRagen and Poseida Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| denalitherapeutics.com | 2015 | San Francisco, United States | $347M | 377 | Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's. | |
| miragen.com | 2007 | Boulder, United States | $111.29M | 92 | MicroRNA-based therapeutics are developed for treating multiple diseases. | |
| poseida.com | 2015 | San Diego, United States | $323.78M | 259 | Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies |
Detailed competitors of GenomOncology
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of GenomOncology
The website of GenomOncology (genomoncology.com) receives about 4.9K visits a month.
- Monthly visits4.9K
▼ 27.7% vs previous month
Websites whose visitors overlap most with GenomOncology. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| genomeweb.com | 100% | 116.4K | #371,609 | View details | |
mycancergenome.org | mycancergenome.org | 100% | #1,118,691 | – | |
| bio-itworld.com | 62% | #1,672,238 | View details | ||
| foundationmedicine.com | 61% | 65K | #611,310 | View details | |
| novartis.com | 61% | 948.8K | #58,822 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for GenomOncology
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as GenomOncology (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genomoncology
Complete news archive for GenomOncology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GenomOncology
GenomOncology was founded in 2012.
GenomOncology is headquartered in Cleveland, United States. It is registered at Cleveland, Ohio, United States.
GenomOncology is a funded company, having raised a total of $6.09M across 5 funding rounds to date. The company's 1st funding round was a Seed of $1.25M, raised on May 2012.
GenomOncology is a healthcare technology company enabling precision medicine by transforming genomic data into actionable information. It has developed a proprietary technology platform to streamline the use of next-generation sequencing in medicine and research. Precision Medicine Portfolio is a suite of products and services that addresses for precision medicine in molecular pathology and medical genetics, particularly in the field of oncology and other hereditary diseases. This portfolio supports test validation and production, clinical decision support, and analytics for both monitoring and discovery. Its other products include the GO Validation Toolkit, the GO Clinical Workbench, and GenomAnalytics. It also offers scientific services like test validation, customization, integration, and research.
GenomOncology's top competitors include Poseida Therapeutics, Denali Therapeutics and MiRagen.
GenomOncology offers Precision Oncology Platform, Data Enablement, Pathology Decision Support, Insights & Analytics, and Curation Services.
GenomOncology has 2 investors. Key investors include TriStar Health Partners, and JumpStart Ventures.
GenomOncology operates through Genomoncology Llc.